| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 123.17B | 115.92B | 106.22B | 98.85B | 91.82B | 86.49B |
| Gross Profit | 24.02B | 22.36B | 20.22B | 19.15B | 17.62B | 16.05B |
| EBITDA | 5.92B | 5.51B | 5.18B | 4.88B | 4.47B | 4.09B |
| Net Income | 3.73B | 3.47B | 3.11B | 2.98B | 2.66B | 2.42B |
Balance Sheet | ||||||
| Total Assets | 69.72B | 61.25B | 61.50B | 55.90B | 52.47B | 50.71B |
| Cash, Cash Equivalents and Short-Term Investments | 4.66B | 8.38B | 10.95B | 8.91B | 9.76B | 11.73B |
| Total Debt | 308.71M | 350.74M | 266.14M | 365.97M | 405.16M | 418.54M |
| Total Liabilities | 27.76B | 21.48B | 24.60B | 21.63B | 20.34B | 20.34B |
| Stockholders Equity | 41.96B | 39.77B | 36.90B | 34.27B | 32.14B | 30.37B |
Cash Flow | ||||||
| Free Cash Flow | -1.44B | -1.21B | 3.15B | 1.83B | 1.02B | 2.82B |
| Operating Cash Flow | 3.85B | 970.96M | 4.58B | 2.56B | 3.25B | 3.18B |
| Investing Cash Flow | -5.22B | -2.52B | -1.58B | -2.58B | -3.91B | -976.23M |
| Financing Cash Flow | -1.55B | -947.53M | -1.06B | -1.03B | -1.00B | -879.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥477.47B | 10.13 | 6.90% | 2.71% | -0.06% | 137.47% | |
77 Outperform | ¥107.56B | 7.99 | 7.53% | 3.01% | 5.44% | 45.99% | |
74 Outperform | ¥81.02B | 12.05 | ― | 6.64% | 2.85% | -9.13% | |
73 Outperform | ¥59.39B | 5.78 | ― | 3.31% | 0.83% | -9.16% | |
72 Outperform | ¥59.73B | 11.44 | ― | 2.88% | 12.39% | 9.81% | |
70 Outperform | ¥150.84B | 4.25 | 10.46% | 2.35% | 4.56% | 49.23% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |